(Q37492223)

20 August 2017

1 reference

title

Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis (English)

1 reference

20 August 2017

Masaru Iwai

1

1 reference

20 August 2017

Masatsugu Horiuchi

series ordinal

2

1 reference

20 August 2017

publication date

22 May 2009

1 reference

20 August 2017

published in

Hypertension Research

1 reference

20 August 2017

volume

32

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

533-536

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.74

20 August 2017

exact match

0 references

cites work

Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Disruption of the Ang II type 1 receptor promotes longevity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

AT2 receptors: functional relevance in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Counterregulatory actions of angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Lessons from SARS: control of acute lung failure by the SARS receptor ACE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Parental imprinting of the Mas protooncogene in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Effects of genetic deletion of angiotensin-(1–7) receptor Mas on cardiac function during ischemia/reperfusion in the isolated perfused mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.74

Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells

21 January 2018

1 reference

12 December 2020

N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE

1 reference

12 December 2020

Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk

1 reference

12 December 2020

International union of pharmacology. XXIII. The angiotensin II receptors

1 reference

12 December 2020

The cardiovascular continuum and renin-angiotensin-aldosterone system blockade

1 reference

12 December 2020

Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells

1 reference

12 December 2020

Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme

1 reference

12 December 2020

Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery

1 reference

12 December 2020

Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide

1 reference

12 December 2020

Angiotensin-(1-7) is a modulator of the human renin-angiotensin system

1 reference

12 December 2020

Identifiers

DOI

10.1038/HR.2009.74

1 reference

20 August 2017

1 reference